Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: A repeated study in 5-year interval
JavaScript is disabled for your browser. Some features of this site may not work without it.
Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: A repeated study in 5-year interval